Evaluation of the long-term safety and effectiveness of tadalafil once daily in Chinese men with erectile dysfunction: interim results of a multicenter, randomized, open-label trial

Article English OPEN
Jiang, Hui; Zhao, Lian-Ming; Lin, Hao-Cheng; Yan, Su; Liu, Ji-Hong; Zhu, Zhao-Hui; Luo, Jin-Dan; Dai, Yu-Tian; Li, Fu-Biao; Lou, Ying; Zhang, Zhi-Chao;
(2018)
  • Publisher: Wolters Kluwer Medknow Publications
  • Journal: Asian Journal of Andrology,volume 20,issue 6,pages587-592 (issn: 1008-682X, eissn: 1745-7262)
  • Publisher copyright policies & self-archiving
  • Related identifiers: doi: 10.4103/aja.aja_47_18, pmc: PMC6219303
  • Subject: Original Article | Diseases of the genitourinary system. Urology | RC870-923 | once-daily dosing | tadalafil | erectile dysfunction; long-term safety; once-daily dosing; tadalafil | erectile dysfunction | long-term safety

Once-daily tadalafil administration has been well established; however, studies about tadalafil once-daily treatment in the Chinese population are lacking. In this phase 4, postmarketing study, we ascertained the long-term safety and effectiveness of tadalafil 2.5 mg an... View more
Share - Bookmark